Clinical Trials in Ohio

Showing 8661-8680 of 15,929 trials

Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia

NCT03214588

The purpose of this study is to evaluate the efficacy of TAK-831 versus placebo on upper extremity (arm and hands) motor function and manual dexterity. This study will also evaluate the efficacy of TAK-831 versus placebo on activities of daily living (ADL) and other secondary assessments.

Friedreich Ataxia

Neurocrine Biosciences67 participantsStarted Nov 2017

Los Angeles, California, United States • Gainesville, Florida, United States • Tampa, Florida, United States +3 more locations

COMPLETEDPhase 332 miles

Efficacy and Safety of SPD503 in Combination With Psychostimulants

NCT00734578

The purpose of this study is to assess the efficacy and safety of SPD503 in subjects with ADHD when co-administered with psychostimulants in children and adolescents aged 6-17 years with a diagnosis of ADHD with a sub-optimal, partial response to stimulants.

ADHD

Shire461 participantsStarted Sep 2008

Dothan, Alabama, United States • Scottsdale, Arizona, United States • Little Rock, Arkansas, United States +58 more locations

Efficacy, Tolerability, and Pharmacokinetics of Multiple Doses of Oral TAK-831 in Adults With Friedreich Ataxia

Efficacy and Safety of SPD503 in Combination With Psychostimulants

Find Trials by Condition in Ohio

Evaluation of Ecallantide for Treatment of Angiotensin Converting Enzyme (ACE) Inhibitor Induced Angioedema

A Study Evaluating the Safety and Efficacy of SM04690 for the Treatment of Moderately to Severely Symptomatic Knee Osteoarthritis

Safety and Efficacy Study of VP20621 for Prevention of Recurrent Clostridium Difficile Infection

Prevention of Recurrence of Diverticulitis

SPD503 in Subjects Aged 6-17 Years With Generalized Anxiety Disorder (GAD), Separation Anxiety Disorder (SAD), or Social Phobia (SoP)

Safety Study of Lifitegrast to Treat Dry Eye

Study Evaluating The Effects Of Neratinib After Adjuvant Trastuzumab In Women With Early Stage Breast Cancer

Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)

A Study for Patients With Neurogenic Orthostatic Hypotension

Cysteamine Bitartrate Delayed-Release for the Treatment of NAFLD in Children

Investigation of Safety+Efficacy of Different Doses of RagweedMATAMPL;Assessment of Residual Allergenicity Using Skin Prick Test

Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study.

A Study to Evaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With Inhibitors

Study of Intrathecal Idursulfase-IT Administered in Conjunction With Elaprase® in Pediatric Patients With Hunter Syndrome and Early Cognitive Impairment

CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial

A Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in Type 1 Diabetes Subjects

A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021

An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.